1-20 of 40
hemophilia a
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gene therapy for hemophilia

Amit C. Nathwani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 1–8.
https://doi.org/10.1182/hematology.2019000007
Published: 2019
Journal Articles

Hemophilia gene therapy comes of age

Lindsey A. George
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 587–594.
https://doi.org/10.1182/asheducation-2017.1.587
Published: 2017
Journal Articles

Using pharmacokinetics to individualize hemophilia therapy

Alfonso Iorio
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 595–604.
https://doi.org/10.1182/asheducation-2017.1.595
Published: 2017
Journal Articles

Novel alternate hemostatic agents for patients with inhibitors: beyond bypass therapy

Margaret V. Ragni
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 605–609.
https://doi.org/10.1182/asheducation-2017.1.605
Published: 2017
Journal Articles

Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches

Shannon L. Meeks, Glaivy Batsuli
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 657–662.
https://doi.org/10.1182/asheducation-2016.1.657
Published: 2016
Journal Articles

Treatment of rare factor deficiencies in 2016

Flora Peyvandi, Marzia Menegatti
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 663–669.
https://doi.org/10.1182/asheducation-2016.1.663
Published: 2016
Journal Articles

New therapies for hemophilia

Steven W. Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 650–656.
https://doi.org/10.1182/asheducation-2016.1.650
Published: 2016
Journal Articles

What is the role of an extended half-life product in immune tolerance induction in a patient with severe hemophilia A and high-titer inhibitors?

Maissaa Janbain, Steven Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 648–649.
https://doi.org/10.1182/asheducation-2016.1.648
Published: 2016
Journal Articles

Diagnosing von Willebrand disease: genetic analysis

Anne Goodeve
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 678–682.
https://doi.org/10.1182/asheducation-2016.1.678
Published: 2016
Journal Articles

Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors

Paul E. Monahan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 33–40.
https://doi.org/10.1182/asheducation-2015.1.33
Published: 2015
Journal Articles

Managing older patients with hemophilia

Dana Angelini, Suman L. Sood
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 41–47.
https://doi.org/10.1182/asheducation-2015.1.41
Published: 2015
Journal Articles

The long and short of it: using the new factor products

Amy Dunn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 26–32.
https://doi.org/10.1182/asheducation-2015.1.26
Published: 2015
Journal Articles

Using genetic diagnostics in hemophilia and von Willebrand disease

Laura L. Swystun, Paula James
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 152–159.
https://doi.org/10.1182/asheducation-2015.1.152
Published: 2015
Journal Articles

Risky business of inhibitors: HLA haplotypes, gene polymorphisms, and immune responses

Birgit M. Reipert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 372–378.
https://doi.org/10.1182/asheducation.V2014.1.372.3884771
Published: 2014
Journal Articles

Replacing bad (F)actors: hemophilia

Christopher B. Doering, H. Trent Spencer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 461–467.
https://doi.org/10.1182/asheducation-2014.1.461
Published: 2014
Journal Articles

Lasting power of new clotting proteins

Jerry S. Powell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 355–363.
https://doi.org/10.1182/asheducation-2014.1.355
Published: 2014
Journal Articles

Toward optimal therapy for inhibitors in hemophilia

Christine L. Kempton, Shannon L. Meeks
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 364–371.
https://doi.org/10.1182/asheducation-2014.1.364
Published: 2014
Journal Articles

Long-lasting recombinant factor VIII proteins for hemophilia A

Amy D. Shapiro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 37–43.
https://doi.org/10.1182/asheducation-2013.1.37
Published: 2013
Journal Articles

The hemophilias and their clinical management

Neil Josephson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 261–267.
https://doi.org/10.1182/asheducation-2013.1.261
Published: 2013
Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.
https://doi.org/10.1182/asheducation-2013.1.44
Published: 2013